Update on the management of infectious keratitis

A Austin, T Lietman, J Rose-Nussbaumer - Ophthalmology, 2017 - Elsevier
Infectious keratitis is a major global cause of visual impairment and blindness, often affecting
marginalized populations. Proper diagnosis of the causative organism is critical, and …

Liposomal Amphotericin B (AmBisome®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions

NRH Stone, T Bicanic, R Salim, W Hope - Drugs, 2016 - Springer
Abstract Liposomal amphotericin B (AmBisome®; LAmB) is a unique lipid formulation of
amphotericin B. LAmB is a standard of care for a wide range of medically important …

Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America

TF Patterson, GR Thompson III… - Clinical infectious …, 2016 - academic.oup.com
It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …

Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America

PG Pappas, CA Kauffman, DR Andes… - Clinical infectious …, 2016 - academic.oup.com
It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …

[HTML][HTML] Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

AJ Ullmann, JM Aguado, S Arikan-Akdagli… - Clinical Microbiology …, 2018 - Elsevier
Abstract The European Society for Clinical Microbiology and Infectious Diseases, the
European Confederation of Medical Mycology and the European Respiratory Society Joint …

[图书][B] Deadly medicines and organised crime: how big pharma has corrupted healthcare

P Gotzsche - 2019 - taylorfrancis.com
PRESCRIPTION DRUGS ARE THE THIRD LEADING CAUSE OF DEATH AFTER HEART
DISEASE AND CANCER. In his latest ground-breaking book, Peter C Gotzsche exposes the …

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America

AG Freifeld, EJ Bow, KA Sepkowitz… - Clinical infectious …, 2011 - academic.oup.com
This document updates and expands the initial Infectious Diseases Society of America
(IDSA) Fever and Neutropenia Guideline that was published in 1997 and first updated in …

Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and …

B De Pauw, TJ Walsh, JP Donnelly… - Clinical infectious …, 2008 - academic.oup.com
Background. Invasive fungal diseases are important causes of morbidity and mortality.
Clarity and uniformity in defining these infections are important factors in improving the …

[HTML][HTML] Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America

PG Pappas, CA Kauffman, D Andes… - … diseases: an official …, 2009 - ncbi.nlm.nih.gov
Guidelines for the management of patients with invasive candidiasis and mucosal
candidiasis were prepared by an Expert Panel of the Infectious Diseases Society of America …

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

R Herbrecht, DW Denning, TF Patterson… - … England Journal of …, 2002 - Mass Medical Soc
Background Voriconazole is a broad-spectrum triazole that is active against aspergillus
species. We conducted a randomized trial to compare voriconazole with amphotericin B for …